Asian Liver Center,
Department of Surgery,
Asian Liver Center, Department of Surgery
Samuel K. So has not added Biography.
If you are Samuel K. So and would like to personalize this page please email our Author Liaison for assistance.
Major hepatic resection without blood transfusion: experience with total vascular exclusion.
Journal of gastroenterology and hepatology May, 1999 | Pubmed ID: 10382635
Does Asian race affect hepatitis B virus recurrence or survival following liver transplantation for hepatitis B cirrhosis?
Journal of gastroenterology and hepatology May, 1999 | Pubmed ID: 10382639
Treatment of hepatocellular carcinoma with sub-selective transcatheter arterial oily chemoinfusion.
Techniques in vascular and interventional radiology Sep, 2002 | Pubmed ID: 12524643
Gallium maltolate is a promising chemotherapeutic agent for the treatment of hepatocellular carcinoma.
Anticancer research May-Jun, 2006 | Pubmed ID: 16827101
The burden of liver cancer in Asians and Pacific Islanders in the Greater San Francisco Bay Area, 1990 through 2004.
Cancer May, 2007 | Pubmed ID: 17385214
Cost-effectiveness of screening and vaccinating Asian and Pacific Islander adults for hepatitis B.
Annals of internal medicine Oct, 2007 | Pubmed ID: 17909207
The Jade Ribbon Campaign: a model program for community outreach and education to prevent liver cancer in Asian Americans.
Journal of immigrant and minority health Aug, 2009 | Pubmed ID: 17990118
Small interfering RNA targeting CDC25B inhibits liver tumor growth in vitro and in vivo.
Molecular cancer Feb, 2008 | Pubmed ID: 18269767
Blockade of Wnt-1 signaling leads to anti-tumor effects in hepatocellular carcinoma cells.
Molecular cancer Sep, 2009 | Pubmed ID: 19778454
Cost-effectiveness of nationwide hepatitis B catch-up vaccination among children and adolescents in China.
Hepatology (Baltimore, Md.) Feb, 2010 | Pubmed ID: 19839061
Disparities in liver cancer incidence by nativity, acculturation, and socioeconomic status in California Hispanics and Asians.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology Dec, 2010 | Pubmed ID: 20940276
San Francisco hep B free: a grassroots community coalition to prevent hepatitis B and liver cancer.
Journal of community health Aug, 2011 | Pubmed ID: 21125320
Soluble Frizzled-7 receptor inhibits Wnt signaling and sensitizes hepatocellular carcinoma cells towards doxorubicin.
Molecular cancer Feb, 2011 | Pubmed ID: 21314951
Doing Good with Good OR: Supporting Cost-effective Hepatitis B Interventions.
Interfaces May, 2011 | Pubmed ID: 21760650
Suppression of glypican 3 inhibits growth of hepatocellular carcinoma cells through up-regulation of TGF-β2.
Neoplasia (New York, N.Y.) Aug, 2011 | Pubmed ID: 21847365
Molecular imaging of hepatocellular carcinoma xenografts with epidermal growth factor receptor targeted affibody probes.
BioMed research international , 2013 | Pubmed ID: 23710458
Suppressing N-Myc downstream regulated gene 1 reactivates senescence signaling and inhibits tumor growth in hepatocellular carcinoma.
Carcinogenesis Apr, 2014 | Pubmed ID: 24302615
Copy number gain of granulin-epithelin precursor (GEP) at chromosome 17q21 associates with overexpression in human liver cancer.
BMC cancer Apr, 2015 | Pubmed ID: 25885205
Medical training fails to prepare providers to care for patients with chronic hepatitis B infection.
World journal of gastroenterology Jun, 2015 | Pubmed ID: 26078568
Fatal Accelerated Cirrhosis after Imported HEV Genotype 4 Infection.
Emerging infectious diseases Sep, 2015 | Pubmed ID: 26291424
NDRG1 promotes growth of hepatocellular carcinoma cells by directly interacting with GSK-3β and Nur77 to prevent β-catenin degradation.
Oncotarget Oct, 2015 | Pubmed ID: 26359353
Suppression of ATAD2 inhibits hepatocellular carcinoma progression through activation of p53- and p38-mediated apoptotic signaling.
Oncotarget Dec, 2015 | Pubmed ID: 26497681
Cost-Effectiveness and Cost Thresholds of Generic and Brand Drugs in a National Chronic Hepatitis B Treatment Program in China.
PloS one , 2015 | Pubmed ID: 26536626
Evaluation of the first open-access hepatitis B and safe injection online training course for health professionals in China.
BMC medical education Mar, 2016 | Pubmed ID: 26952079
Disparities in hepatocellular carcinoma incidence by race/ethnicity and geographic area in California: Implications for prevention.
Cancer 09, 2018 | Pubmed ID: 30113700
Racial/ethnic- and county-specific prevalence of chronic hepatitis B and its burden in California.
Hepatology, medicine and policy , 2018 | Pubmed ID: 30288329
An NIR-II/MR dual modal nanoprobe for liver cancer imaging.
Nanoscale Jun, 2020 | Pubmed ID: 32428058
ACERCA DE JoVE
Copyright © 2024 MyJoVE Corporation. Todos los derechos reservados